Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 27, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 29, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001910132-26-000007
Filed / recorded
Jul 29, 2026, 8:10 PM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
SPRUCE BIOSCIENCES, INC.
Issuer CIK
1683553
Ticker
SPRB
Reporting person
Adrian W Quartel
Relationship
Officer
Officer title
Chief Medical Officer
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Jul 27, 2026
Transaction code
A
Shares / units
13,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
13,000
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
25% of the total number of restricted stock units ("RSUs") will vest on June 15, 2027. 25% of the total number of RSUs will vest on each of June 15, 2028, June 15, 2029 and June 15, 2030, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date.